Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Detection of acute hepatitis C virus (HCV) infection before the appearance of HCV antibodies in serum (ie, <2 months from exposure)
Detection and confirmation of chronic HCV infection
Quantification of HCV RNA in serum of patients with chronic HCV infection (HCV antibody-positive)
Monitoring disease progression in chronic HCV infection and response to antiviral therapy
Determining cure and detection of relapse after completion of antiviral therapy
A reflex test for serum specimens that are hepatitis C Virus (HCV) antibody screen-reactive for diagnosis of chronic hepatitis C.
This test is appropriate for diagnosis of acute hepatitis C in high-risk or immunosuppressed individuals who may be negative for HCV antibodies.
This test can be used to establish a baseline HCV viral load before initiating antiviral therapy for chronic hepatitis C.
This test can be used to monitor response and progress during antiviral therapy for chronic hepatitis C.
This test is appropriate for confirming a sustained virologic response and detecting a relapse of hepatitis C after completion of antiviral therapy.
The following algorithms are available in Special Instructions:
-Chronic Hepatitis C Treatment and Monitoring Algorithm: Direct Antiviral Antigen (DAA) Combination
Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR)